[Propofol-midazolam in continuous infusion for sedation in intensive care].
Two groups of 11 ICU respiratory patients ventilated with PSV have been sedated with propofol (group I) or with midazolam (group II). After the endovenous administration of the induction dose (propofol 1.5 mg/kg; midazolam 0.15 mg/kg) sedation was obtained with continuous infusion of the drugs (propofol 2 mg/kg/h; midazolam 0.24 mg/kg/h). In this setting the Authors evaluated the level of sedation (Ramsey scale) and the side effect of the two drugs. At induction midazolam caused a reduction of tidal volume for some minutes and a greatest sedation in comparison with propofol, while propofol caused reduction of MAP (p < 0.01) and transitory apnoea. Even if during the infusion of propofol the level of sedation decreased with time (p < 0.05; y = -0.0357 x + 3.07) it was more stable in comparison with that registered during continuous infusion of midazolam (p < 0.01; y = -0.2018 x + 5.19.
Pappagallo
S
S
UO Anestesia e Rianimazione, USSL n. 18, Empoli, Firenze.
Giannoni
S
S
Romagnoli
P
P
Viviani
V
V
Tinacci
S
S
Tulli
G
G
D000368:Aged; D016292:Procedural Sedation; D003422:Critical Care / Q000379:methods*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008874:Midazolam / Q000008:administration & dosage; D008875:Middle Aged; D015742:Propofol / Q000008:administration & dosage; D012121:Respiration, Artificial
D008874:Midazolam; D015742:Propofol
Propofol-midazolam in infusione continua per la sedazione in terapia intensiva.